REDHILL BIOPHARMA LTD. (RDHL) Gross profit 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual gross profit history from SEC filings — each fiscal year as reported.
$4.9MFY2024 · since FY2015: $3,000 → $4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $4.9M | +58.0% |
| FY2023 | $3.1M | -89.2% |
| FY2022 | $28.5M | -21.7% |
| FY2021 | $36.4M | +32.3% |
| FY2020 | $27.5M | +581.2% |
| FY2019 | $4.0M | -27.0% |
| FY2018 | $5.5M | +193.6% |
| FY2017 | $1.9M | +1762.4% |
| FY2016 | $101,000 | +3266.7% |
| FY2015 | $3,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice